19 September, 2021 by The TZ Newswire Staff Comments Off on Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19
Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19
SHANGHAI, China, Sept.
19 September, 2021 by The TZ Newswire Staff Comments Off on $1,000 Invested in These 3 Stocks Could Change Your Life in 20 Years
$1,000 Invested in These 3 Stocks Could Change Your Life in 20 Years
Holding positions in great companies long term could change your life. Amazon stock has surged roughly 40,000% over the last two decades, which means a $1,000 investment made in the company would now be worth roughly $400,000. Buying Netflix stock at its initial public offering back in 2002 would have yielded even better results, and a $1,000 investment in the entertainment company would now be worth about $492,000 based on today’s stock price.
19 September, 2021 by The TZ Newswire Staff Comments Off on Got $1,000? Here Are 2 Unstoppable Dividend Stocks to Buy
Got $1,000? Here Are 2 Unstoppable Dividend Stocks to Buy
Aside from the COVID-19-induced bear market in March 2020, the past few years have been difficult for income investors. The S&P 500‘s average yield has been less than 2% in 44 of the past 48 months, which can make it more challenging to find companies whose payouts are both attractive and sustainable.
But even in a market consistently reaching record highs, there do exist sanely priced stocks offering safe dividend yields that are double to nearly quadruple the S&P 500’s current 1.3%.
19 September, 2021 by The TZ Newswire Staff Comments Off on CySEC Crypto, FX Results, Solana, NAGA, XRP Optimum Price: Editor’s Pick
CySEC Crypto, FX Results, Solana, NAGA, XRP Optimum Price: Editor’s Pick
ICYMI: the biggest news stories of the week